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ABSTRACT 
 
 
Lindeken, Kimberly Lynn. Pain Management in Primary Care. Unpublished Doctor of  
 Nursing Practice capstone project, University of Northern Colorado, 2017. 
 
 Pain management, opioid addiction, opioid diversion, opioid overdose, and 
prescription fraud continue to rise to epidemic levels in the United States.  As primary 
care continues to manage a large proportion of these patients, multiple barriers exist that 
prevent proper pain management.  Pain management specialists are no longer available to 
see patients, documentation on pain management patients is lacking and sub-par, and 
access to the prescription drug-monitoring program (PDMP) is challenging.  Recent 
guidelines released by the Centers for Disease Control and Prevention (CDC; 2016a) 
indicated patients should no longer be on greater than 90-120 morphine milligram 
equivalents a day.  These guidelines also are useful for providers to decide when to 
initiate opioid therapy, provide information on appropriate selection of opioids including 
necessary follow-up and monitoring, along with the need of screening tools to assess risk 
related to opioid therapy.  This capstone examined pain management in primary care, 
ways to improve documentation, increase patient safety and prescriber adherence to CDC 
guidelines, as well as PDMP access and use--all in hopes of creating safe practices in 
primary care regarding pain management due to specialists being unavailable.      
 Keywords:  documentation, opioid, ORT, pain management, primary care 
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CHAPTER I 
 
 
STATEMENT OF THE PROBLEM 
 
 
Introduction and Background  
 
 Pain management, opioid addiction, opioid diversion, opioid overdose, and 
prescription fraud continue to rise to epidemic levels in the United States.  A recent report 
completed by the Institute of Medicine (IOM; cited in American Academy of Pain 
Medicine [AAPM], 2013) found 100 million Americans suffer from pain.  Estimations 
indicated nearly two-thirds of office visits in primary care are due to musculoskeletal 
pain (Hand, 2016).  The financial burden of pain treatment in the United States is over 
half a trillion dollars annually (AAPM, 2013).   
 A study completed by the Centers for Disease Control and Prevention (CDC; 
(2016b) found patients prescribed opiate medication for non-cancer related pain resulted 
with an opioid related overdose in 1 in 550 patients.  Additional findings included 1 in 32 
patients who had a prescription greater than 200 morphine milligram equivalent (MME) 
resulted in death (CDC, 2016b).  
 Bringing the ramifications of opioid abuse to the forefront of the news are the 
latest celebrity deaths from overdose.  Recently, Prince overdosed on fentanyl, a 
synthetic opioid that is 50-100 times more potent than the opioid morphine, at the young 
age of 57 (Drug Enforcement Agency [DEA], 2015).  Far too many deaths have resulted 
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from opiate abuse; even Elvis’ death can be attributed to opiate abuse evidenced by 
codeine discovery in his system (Cable News Network, 2016).    
 Fentanyl is abused due to its euphoric effects and is an alternative for individuals 
abusing heroin (DEA, 2015).  However, fentanyl is a dangerous substitute for heroin 
because of its potency, resulting in respiratory depression and death (DEA, 2015).  Drug 
overdose resulting in death accounted for one and a half more deaths than that of motor 
vehicle crashes (MVC) in the year 2014 in the United States (CDC, 2014).  In Larimer 
County, the county coroner determined 39 deaths were related to complications resulting 
from opiate use in the year 2015 (Rieck, 2016).  The CDC estimated out of every 100 
Coloradoans, 71 had a prescription for opiate medication in 2012 (Rieck, 2016). 
 Current practice has multiple challenges and barriers related to pain management 
in primary care.  Provider availability along with adequate time spent with pain 
management patients are lacking.  Many patients have been allowed to slide by without a 
legitimate diagnosis in their chart or electronic medical record (EMR) while receiving 
pain medication for longer than 90 days.  Often times with the lack of availability on 
provider schedules, these patients have been allowed to call in for a refill, have it printed, 
and then pick it up without ever seeing the provider for up to a year.  This goes against all 
current recommendations, best practice, and is a disservice to the patient, resulting in no 
assessments being charted documenting what kind of pain, where the pain was, and, more 
importantly, if the pain was relieved with the medication.   
 Therefore, many patients are drug seeking, using their medication inappropriately, 
and even selling the medication.  Referrals to pain management coordinators are 
increasing in frequency, leading providers to close their practices to new patients and 
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creating frustration for both patient and provider.  There is a clear supply and demand 
problem with pain management and the provider-to-patient ratio is not favorable for 
anyone involved.  Frustrations, poor access, most especially to those in the lower socio-
economic class, and weak follow-up leave the patient with little to no options when 
searching for pain relief.   
 The prescription drug-monitoring program, while originally created to help track 
opiate abuse, is cumbersome and many providers are unable to gain access to this system 
as the passwords are changed every three months without their knowledge.  Therefore, 
providers are incapable of accessing the program; as a consequence, the program is not 
utilized as it should be, potentially resulting in the patient having multiple providers 
prescribing controlled substances.         
 Contemporary health care is a business, consequently moving away from the 
medical and nursing culture that was originally intended.  According to Loeser and 
Cahana (2013), “Capitalism has overtaken the traditional mores of health care; profits are 
the bottom line, not efficacy or humanity of care” (p. 311).  Loeser and Cahana also 
stated that although the premise of evidence-based medicine continues to be discussed as 
a driving force in health care, the bottom line remains economics when it comes to 
change in health care.  A multidisciplinary approach to pain management would best suit 
the chronic pain patient; however, from a financial standpoint, this is not economically 
possibly with current practice (Loeser & Cahana, 2013).   
 Present-day practice has created an angry culture regarding pain management.  
Pain, especially chronic pain with little relief, can cause a variety of emotions for the 
patient suffering.  These emotions might come across as rudeness and irritation to staff 
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who are attempting to appease the patient.  When a frustrated patient calls an office for an 
appointment or a refill and the perception is they are rude, this then frustrates office staff.  
This is where the culture of anger is perpetuated surrounding pain management.  When 
no appointment is available or the refill is early, the frustration accelerates, thus 
increasing emotions and further disseminating the culture of anger.   
 The practice setting for this capstone is a large family practice in Northern 
Colorado where 58 providers serve an estimated patient population near or greater than 
90,000.  The clinic cares for an entire spectrum of ages including obstetrical, pediatric, 
adult, and geriatric.  The clinic is working on quality improvement projects with one 
focusing on pain management in primary care.  This practice is aware of the frustrations, 
barriers, limitations, and provider education needed to ensure patient safety is met and 
held to the highest standards.   
Problem Statement 
The following Population/Patient Problem, Intervention, Comparison, Outcome, 
and Time (PICOT) problem statement was developed: 
• P--The problems with pain management in primary care surround the main 
barriers primary care providers (PCP) face.  Barriers include prescription 
drug monitoring program (PDMP) access, pain management coordinators 
closing practices to new patients, and improved documentation.  The 
population on which this study was focused included patients on opioid 
therapy for greater than 90 days.  The list included medications on the 
controlled substance II list, which were pulled from the EMR, over the past 
six months for the two office locations chosen for the pilot program.   
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• I--Improving pain management documentation by ensuring pain 
management contracts are signed and reviewed annually as well as 
utilization of an opioid risk tool (ORT; Webster & Webster, 2005) annually, 
which would then identify the patient as low, moderate, or high risk.  Based 
on this stratification, the patient would need to be seen in the office at 
regular intervals, ranging from monthly to every six months.  This also 
determines the frequency of checking the PDMP and regularity of random 
drug screens.   
• C--The only alternative to this plan was to refer all pain management 
patients to a pain specialist, thus not treating the patient.   
• O--Desired outcomes would be improved charting, increased adherence by 
providers and patients with the utilization of the pain management contract, 
increased frequency of office visits for moderate and high-risk patients as 
identified with the ORT, and improved provider satisfaction regarding pain 
management treatment.  Outcomes would be measured using chart reviews 
ascertaining specific data point’s pre- and post-implementation.   
• T--The time frame for the capstone project was projected to be six months.  
Review of Literature 
 A literature review was conducted to assess current research, problems, and 
solutions regarding pain management in primary care.  Databases utilized include 
Cumulative Index of Nursing and Allied Health Literature, UptoDate, and Nursing and 
Allied Health.   
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 Pain management affects more individuals in the United States than strokes, 
coronary heart disease, and cancer combined (McCarberg, 2011).  Opioid analgesics have 
become the most prescribed medication in the United States.  Prescriptions for opioid 
medications are at a high risk of being misused, sold, or diverted (McCarberg, 2011).  
Primary care physicians are faced with a slippery slope when it comes to treating pain.  
Unavoidable consequences occur when pain is undertreated; yet with current trends, 
opioid addiction, diversion, and abuse are rampant (McCarberg, 2011).  The challenge of 
properly documenting and treating a patient with a 15-minute appointment is daunting for 
most PCPs.  One third of patients seeking care for pain management by primary care 
resort to emergency rooms for pain management as they feel their pain is not well 
managed.  Screening patients at the onset of long-term pain management therapy for risks 
of addition, aberrant behavior, and depression is recommended for primary care providers 
(McCarberg, 2011).   
 According to Hudspeth (2016), opioid misuse is increasing.  It is well documented 
that patients seek treatment for pain management in primary care.  Many providers 
prescribing opioid prescriptions are not specifically trained in pain management.  In fact, 
it is estimated nearly 50% of prescriptions for pain management medications are from 
PCPs who lack formal education surrounding pain (Hudspeth, 2016).   
 Chronic pain is prevalent in today’s society including extensive media coverage. 
“Chronic pain is one of the most important issues in both medicine and public health” 
(Mills, Torrance, & Smith, 2016, p 1).  Accurately assessing chronic pain can be 
challenging due to the multifactorial process present with chronic pain.  Additional 
factors to consider when assessing pain include psychological, social, and physical (Mills 
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et al., 2016).  Depression screening and setting pain management goals are recommended 
upon initiation of pain management in primary care (Mills et al., 2016).   
 It has been estimated that 70% of chronic pain patients are managed by PCPs 
(Johnson, Collett, & Castro-Lopes, 2013).  Primary care practices in Europe are facing 
similar pain management problems.  The article found slightly less than half of European 
providers utilized a pain assessment tool (Johnson et al., 2013).  Of the providers who 
were not using a pain assessment tool, reasons given included lack of understanding on 
how to use the tool, time restrictions, feelings that the tool was not helpful, and 
preference to talk to the patient (Johnson et al., 2013).    
 A systematic review on pain management programs completed by Chipchase, 
Sheffield, & Hill (2012) found literature available regarding this subject was scarce.  
Chipchase et al. originally sought out “high quality randomized control trials 
incorporating long-term follow-ups, and comparisons with both wait list and control 
treatments” (p. 216) but discovered this type of research did not yet exist.  During the 
quality review of the study, many of the studies included in the systematic review were 
found to be of moderate quality due to differences in the sampling methods and various 
follow-up periods (Chipchase et al., 2012).   
 Prior to therapy initiation, Gupta and Rosenquist (2016) stated the risk of 
overdose and/or an opioid abuse or opioid dependence disorder should be calculated.  
Once a risk was measured, the decision to prescribe opioid therapy could be better 
weighed (Gupta & Rosenquist, 2016).  If the patient was found to be at high risk, 
recommendations were to avoid opioid therapy if possible.  If opioid therapy was 
necessary with a high-risk patient, close monitoring or referral to a pain management 
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specialist was warranted (Gupta & Rosenquist, 2016).  If the decision to prescribe an 
opioid was selected by the provider, a pain management contract was recommended.  The 
contract would delineate the patient was to only take the medication as directed and what 
monitoring the patient could expect while on opioid therapy.  Monitoring of opioid 
therapy included random urine drug screens, PDMP review, and frequent office visits 
(Gupta & Rosenquist, 2016).   
 Formal research surrounding improving pain management utilizing CDC (2016a) 
guidelines for opioid therapy was also lacking.  The guidelines were released in the 
summer of 2016; therefore, research is highly needed and possibly underway.  This 
illustrated the importance of this capstone.  Improving pain management given the 
epidemic levels of opioid misuse, diversion, and overdose is not only better patient care 
but imperative to correcting the culture within the United States surrounding opioids.  
Theoretical Framework 
 Utilizing Rogers’s (1997) diffusion of innovation theory allowed the researcher to 
focus on how the information was dispersed to staff--from the providers to the nurses and 
the front office staff (see Figure 1).  The purpose of focusing on the dispersion of 
information was to ensure the staff received the new protocol in a positive light rather 
than in a negative or mandatory manner.  Often when new information regarding 
workflows or process improvement is explained to staff, it seems cumbersome or appears 
to increase workload; therefore, an automatic negative tone is assumed and is hard to 
overcome.    
 Rogers’s (1997) diffusion of innovation theory seeks to explain and understand 
why certain new ideas are successful and others are not.  Furthermore, this theory also 
9 
 
examines how some new innovations are adopted by members within the social system 
and the direct relationship between this perception and adoption (Rogers, 1997).   
 
 
Figure 1. Diffusion of innovation model (Rogers, 1997). 
 
 The concepts within this theory are innovation, communication, time, and social 
system (Rogers, 1997).  First is innovation--what new idea or protocol is being 
introduced?  How long will the new improvement be analyzed and formulated?  After a 
new idea or advancement is discovered or created, communication is a factor.  
Communication aims to understand how individuals are hearing or talking about the new 
idea.  Subjective evaluations by the individuals influence how communication is carried 
out.  Often when a new innovation is constructed, perception of the idea affects how 
individuals spin this idea amongst their peers.  
 Time is also an element with the concept of innovativeness.  When a new idea is 
constructed, the individual enters into the innovation-decision process (Rogers, 1997).  
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This is simply how the person comes to the idea, what their attitude is regarding the 
innovation, how they feel about adopting or rejecting said idea, and, lastly, how they 
communicate this to others (Rogers, 1997).  Rogers (1997) defined innovativeness as “the 
degree to which an individual or other unit of adoption is relatively earlier in adopting 
new ideas than other members of a social system” (p. 2).  The five categories of adoption 
are based on acceptance of the new innovation: innovators, early adopters, early majority, 
late majority, and laggards (Rogers, 1997).  The rate of adoption of the innovation is the 
third aspect of time by looking at how quickly or slowly the social system embraces the 
innovation.   
 The last constituent of this theory is social system.  Rogers (1997) defined social 
system as a group of unified elements involved in shared problem solving.  With this 
definition, a social system can be a large community working towards a common goal or 
a committee striving to improve processes within a system.  Assumptions within the 
theory are that all individuals in the social system would hear about the innovation and be 
in a group of innovators, adopters, majority, or laggards.   
 The theory has been applied in various settings to ascertain its effectiveness.  In 
one setting, the theory was applied by Lee (2004) in three intensive respiratory care units 
in Taiwan.  The theory was utilized to ascertain nurse’s perspectives regarding a charting 
system on the computer.  The theory fit nicely with the introduction of the new computer 
system among the 12 nurses who participated (Lee, 2004).  The results indicated the 
nurses felt the system saved time and paper but also felt there were problems with the 
system if the printer was broken or if down time was occurring (Lee, 2004).  Overall, the 
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theory was a nice predictor of the various stages where participants accepted a new idea 
or change into a system (Lee, 2004).  
 In an emergency department in Switzerland, Rogers’s (1997) theory was applied 
regarding a pain management protocol (Hadorn, Comte, Foucault, Morin, & Hugli, 
2016).  General conclusions of the study showed the majority of the nursing staff felt the 
protocol was easy to follow and read.  The results also indicated the nursing staff felt 
positively about the pain management protocol within the emergency department.  The 
advantages of the protocol included quality improvement and better care.  The negative 
finding regarding the protocol was technologically based and focused on software 
limitations by an inability to write the protocol into the current software within the 
hospital.  The research paper by Hadorn et al. (2016) assessed an intervention eight 
months after the protocol was introduced to the emergency department in a Swiss 
hospital. Rogers’s has found that those who have a higher education or who are more 
affluent tend to adapt to change much easier and more willingly than others (Hadorn et 
al., 2016).   
 The implementation of a pain protocol within the emergency department in 
Switzerland was not guided by Rogers’s (1997) theory.  Following implementation, the 
theory was utilized to assess nurses’ perceptions of the protocol, it’s feasibility, and how 
the nurses felt the protocol fit into their practice.  The nurses within the emergency 
department in Switzerland who responded to the survey felt the protocol worked well 
with their nursing role (Hadorn et al., 2016).  Additionally, the nurses felt the protocol 
improved the quality of care for patients and providers but also for themselves (Hadorn et 
al., 2016).   
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 Analyzing the protocol using Rogers’s (1997) theory presented limitations due to 
the fact that the implementation had happened eight months prior.  Because of this, there 
was no way to measure testability (Hadorn et al., 2016).  The model by Rogers did 
improve understanding of all the necessary steps and stages an innovation needs to be 
successful including communication among the social structures (Hadorn et al., 2016).    
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CHAPTER II 
 
 
PROJECT DESCRIPTION 
 
 
Project Objectives 
 It is not uncommon for pain management coordinators to be overwhelmed by 
large amounts of patients needing chronic pain management and, therefore, needing to 
turn these patients away.  Due to this, PCPs manage large amounts of patients with 
chronic pain.  To provide safe and high quality care to pain management patients, this 
capstone examined various ways to improve pain management in primary care.  There 
were multiple objectives for this capstone project:  
• Improved documentation for pain management patients. 
• Utilization of the PDMP when appropriate. 
• Increased frequency of office visits. 
• Implementing and following the newly released guidelines by the CDC 
(2016a) regarding pain management and prescribing practices.    
 The CDC (2016a) recently released guidelines for providers to utilize when 
presented with managing chronic pain.  These guidelines suggested when to begin opioid 
therapy, how to manage therapy including titration and selection of an opioid, and how to 
screen for risks and or harms that coincided with opioid use (CDC, 2016a).   
 This capstone project followed the guidelines recommended by the CDC (2016a) 
by ensuring improved documentation for chronic pain patients, which would assist in 
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better management of this patient population.  Currently, no template is followed when 
seeing a chronic pain patient and often there is no diagnosis to support the need for pain 
management.  With this lack of documentation, there is also no clear definition of when 
appropriate follow-up should occur, which also is not effective patient care.  Many 
patients have not filled out a pain management contract or completed a risk assessment 
tool, leaving the provider without the necessary or recommended information to safely 
manage pain.   
 To improve documentation on pain management patients, providers, nursing staff, 
front office staff, and office managers were educated regarding the pain management 
pilot.  The patients identified as chronic pain patients would need to have an annual pain 
management contract signed.  The nursing staff and provider seeing the patient would 
need to ensure this was available, signed at the visit by the patient, and scanned into the 
patient’s chart.  At this same appointment, the ORT (Webster & Webster, 2005) would be 
used to assess risk of deviant behavior.  Based on this stratification scale from the ORT, 
the patient would need follow-up in the office either every month, every other month, or 
every three months.  This appointment would be scheduled prior to the patient leaving the 
office.  
 Utilizing the pain management template within EPIC (2016), the EMR charting 
system for the clinic also served to improve documentation on pain management patients.  
Within the template were various assessments built in to clue the provider on improved 
charting specific to pain patients.  A proper diagnosis code, if not already in the chart, can 
be placed in this template.    
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 Another objective within the capstone was to use the PDMP when appropriate, 
which based off the ORT stratification, would guide providers and nursing staff on 
appropriate use.  The PDMP has historically been difficult to access when not used 
frequently.  The program has security features including frequent password changes, 
often without notification to the user.  This creates difficulty when accessing as the user 
is no longer aware of the password due to the system automatically changing it for 
security purposes.  The hypothesis was with more frequent access, the provider would 
know the password if he/she used the system more often.   
 The ORT (Webster & Webster, 2005) stratification provides recommendations on 
office visit frequency, which would ultimately increase office visits.  An increase in visits 
would allow the provider to reassess--an important part of treating any illness.  This 
increase in office visits would add to the provider’s workload with high-risk patients; 
however, the hope was by providing safe patient care, an overall decrease of 
inappropriate health access would follow.  Inappropriate access would be emergency 
room visits for pain control and frequent phone calls to pharmacies and providers for 
refills, resulting in overall frustration for all involved.  Current practice had allowed 
patients to slip through the cracks—patients who often called for refills of controlled 
substances and not to have their pain reassessed.  The hope was by scheduling chronic 
pain visits with their PCP the patient would have improved care and the provider would 
have more time with the patient to better assess effectiveness of the treatment plan.   
 The guidelines released by the CDC (2016a) regarding opioid prescriptions have a 
great deal of information.  The implications of the guidelines are important--not only to 
providers but to patients.  The guidelines strive to achieve patient safety and best practice.  
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It is recommended that no patient be on more than 90-120 MME daily.  During the chart 
review process of the capstone, MME was calculated on chronic pain patients.  Of those 
patients found to be on greater than 90-120 MME daily, the provider was notified.  All 
patient information was confidential and de-identified.  Upon reevaluation of the 
capstone implementation, the chart audits would look at patients found to be on higher 
than recommended MME doses to assess if the provider had initiated decreased therapy.    
Evidence-Based Project Plan  
 Identifying pain management patients who are at high risk for aberrant behavior 
with the use of the ORT (Webster & Webster, 2005) might be helpful in providing 
needed documentation to ensure patient care was competent, safe, and appropriate.  This 
capstone project occurred in three main phases.  Two offices were selected to run the 
pilot for pain management in primary care.  Both locations in Northern Colorado offer 
primary care to the entire age spectrum.  Providers in the pilot included seven medical 
doctors (MDs), three doctors of osteopathic medicine (DOs), one advance practice 
registered nurse (APRN), and one physician assistant (PA).   
Phase One  
An overview of the current state of pain management within primary care through 
chart reviews was conducted.  During phase one, the top three barriers to pain 
management at the practice were reviewed: PDMP access and use, pain management 
coordinators and their availability, and documentation surrounding chronic pain patients.  
As stated earlier, PDMP access has been a frustration for providers.  Currently, this 
program has not been utilized and safety for the patient has been compromised due to 
access issues.  Providers often attempted to retrieve data but due to time restrictions and 
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packed schedules with other patients, information was not successfully accessed when 
needed.   
 Controlled II substance prescriptions were reviewed with chart audits (see Figure 
2).  The researcher conducted chart analyses to find patients on chronic pain medication 
defined by those using opioid medication for more than 90 days.  The goal was to 
eliminate any acute pain management patients from the pilot.  For the purpose of this 
capstone, acute pain management was defined as opioid medication used for less than 90 
days.  During the chart audits, overall assessment of current documentation regarding 
pain management was completed.  Items assessed included appropriate diagnosis, pain 
management contract in the chart, ORT assessment tool completed and in the chart, 
follow up clearly delineated within the office note, and if a follow ufp appointment was 
scheduled.  Exclusion criteria from the pilot included medications not used for pain 
management that were also controlled II medications, patient age under 18, short-term 
pain management for acute problems, and a diagnosis of cancer.     
 
 
Figure 2. Schedules of controlled substances (DEA, 2016).   
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Phase Two  
 Data collected in phase one were assessed in phase two.  Data collected were 
directly related to current documentation of pain management.  The chart audits obtained 
the following data points on various patients identified as chronic pain management 
patients: 
• Pain management contract in the chart 
• Opioid risk tool assessment completed and in chart 
• Prescription-drug monitoring program access 
• Diagnosis code in chart 
• Follow-up outlined in chart or last pain management visit note 
• Review of future appointments to distinguish if follow up was scheduled 
 Following the assessment of the data from phase one, education sessions were 
provided at both offices with all staff within the office.  The education sessions utilized 
current recommendations released by the CDC (2016a) to manage chronic pain and set 
standards within the practice.  The key players for the education sessions included office 
managers, front desk staff, nursing staff, providers within the clinic, the Doctor of 
Pharmacy, and the researcher.  The education included a review of the currently approved 
pain contract, where to locate the contract, and expectations of when to review, update, 
and sign the contract.  The pain contract utilized is provided in Appendix A.  Following 
the contract review was an introduction to the ORT (see Figure 3), which would be 
completed after the pain contract was signed (see Figure 3). 
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Figure 3. Opioid risk tool (Webster & Webster, 2005).  
 
 The ORT (Webster & Webster, 2005) assessment takes less than one minute to 
administer and will assist providers in determining if the patient is low, moderate, or high 
risk for deviant behaviors (see Figure 4).  Once scored, the provider would then have 
specific guidelines delineating the frequency of visits for future prescription refills.  Low-
risk patients would need office visits every six months at a minimum.  Moderate-risk 
patients would be expected to have office visits every three months for refills.  High-risk 
patients would need office appointments every month to every other month, random urine 
drug screens, and PDMP checks by the provider at his/her discretion.  This education 
follows CDC’s (2016a) guidelines for prescribing opioid therapy for chronic pain, which 
strives to improve safety, improve communication, and reduce the risks of chronic opioid 
therapy.   
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Figure 4. Warning signs of potential aberrant drug-related behavior (McCarberg, 2011).  
 
Phase Three  
 During this phase of the capstone, evaluation of education to improve pain 
management was assessed.  Retrospective chart reviews were completed to assess the 
same data points reviewed in phase one.  The researcher was able to ascertain if there was 
an improvement in pain management documentation by assessing the same data points 
post intervention.  The patients identified in phase one with greater than 90-120 MME 
daily also had chart audits completed.  During these audits, the reviewer looked for 
documentation regarding decreased titration of opioid therapy.   
Congruence 
 The practice strives to maintain its mission of providing compassionate and 
convenient care to its patients.  The vision of the practice is to provide care to patients 
and maintain health in their neighborhood.  The practice achieves this vision by having 
multiple locations in the area in addition to providing pain management to their patients.  
The mission and vision fit nicely with the capstone by providing convenient, 
compassionate care in the patient’s neighborhood.  Pain management within the patient’s 
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geographical area improves patient satisfaction by decreasing travel time for a patient to 
get the care they desire.  
Timeline 
 The capstone project used the following timeline: 
• Summer 2016--Phenomenon of interest approval 
• Summer 2016--Literature review and synthesis 
• Fall 2016--Initial writing of proposal for project completed 
• November 2016--Defense of capstone proposal  
• December 2016--Institutional Review Board (IRB) consideration and 
approval as well as Statement of Mutual Agreement (see Appendix B) 
• January 2017--Phase one   
• January-April 2017--Phase two 
• May 2017--Phase three 
• May 2017--Final evaluation  
• June 2017--Capstone project completion 
• June 21, 2017--Capstone defense 
Resources 
 The various resources needed for this project included but were not limited to an 
information technology member to pull data from the EHR, provider cooperation, nursing 
and medical assistant staff, front desk staff to check in patients and schedule additional 
follow up appointments, office manager, ORT (Webster & Webster, 2005) in all patient 
rooms, along with various office medical supplies.  Additional resources included the 
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opioid committee and their time assisting in pushing this project forward via 
communication to the nine other offices within the practice if the pilot was successful at 
the two offices.   
 Currently, a provider at the clinic is already working on a template for pain 
management that would allow providers to pull the information necessary for appropriate 
documentation.  Additionally, the EPIC (2016) IT contact for the clinic was asked to 
create a report of the medications prescribed by providers within the offices for the 
original chart review.    
 Capstone committee members were also utilized as resources.  Karen Hessler, the 
capstone chair, was an invaluable resource.  Lory Clukey, a committee member, provided 
insight into pain management.  Amy Stump served as the outside committee member and 
is also employed at the locations where the pilots were implemented.   
Stakeholders 
 Stakeholders for this capstone project included the University of Northern 
Colorado, specifically the School of Nursing, the Graduate School, and the committee 
members for the capstone project.  Stakeholders at the primary care practice included 
Amy Stump, the pharmacist staffed at the offices and also a committee member, 
providers prescribing opioids for pain management, office staff, medical assistants 
(MAs), licensed practical nurses (LPNs), RNs, the quality improvement specialist--Beth 
King, the IT department, the office managers, and the medical director. 
Strategic Analysis  
 Strategic analysis for the capstone project utilized the strength, weakness, 
opportunities, and threats tool (SWOT).  The SWOT tool is useful when analyzing the 
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success or failure of a quality improvement project.  Analyzing success or failure of 
process improvement is necessary to ascertain if change is beneficial to practice.   
 Strengths of the project included the primary care practice seeking practice 
improvement with the pain management pilot.  Additional assets were the recently 
released guidelines from the CDC (2016a) outlining pain management practices.  
Furthermore, the practice has a large patient population, with many patients utilizing 
primary care for pain management, which increased the sample population to assess for 
practice change.  
 Weaknesses associated with the capstone were problems retrieving data from the 
EMR, provider resistance to practice change despite recommendations, and time 
constraints.   
 Various opportunities existed within this capstone, some of which included 
practice improvement, increased patient and provider satisfaction, increased patient 
safety, and better utilization of the PDMP by staff members.   
 Threats to the capstone included provider resistance, patient dishonesty, time 
constraints, and an unwillingness to change current practice by providers, nursing staff, 
and office staff.   
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CHAPTER III  
 
 
EVALUATION PLAN 
 
 
Project Evaluation 
 As there were multiple objectives within this capstone, the need for measuring 
and evaluating the success or failure were of utmost importance.  Assessing improved 
documentation on pain management patients consisted of chart reviews.  Initially, the 
chart assessments consisted of retrospective data retrieval using medications pulled from 
the controlled II substance list.  From these results, data points measured included 
appropriate diagnosis code in the chart, pain management contract in the chart, and ORT 
(Webster & Webster, 2005) assessment completed.  Additional objectives evaluated 
included frequency of office visits for pain management patients based on the ORT 
stratification.   
 The second barrier to pain management in primary care addressed was PDMP use 
and ease of use.  Current practice frustrations were this program was not easy to use and 
did not notify the user when the password was due to expire, thereby changing the 
password unbeknownst to the user.  Providers found it hard to access the information 
when needed and already had time constraints against them with 15-minute 
appointments.    
 Additional objectives to evaluate included daily MME dose to ensure the 
recommended dose of 90-120 MME was not exceeded as recommended by CDC (2016a) 
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guidelines.  Documentation was assessed as well as communication between office 
members regarding pain management patients.  Based on the reviews, patients discovered 
to be on greater than 120 MME daily were flagged and followed to ensure proper titration 
was initiated to decrease the daily dose.    
Phase One 
 Phase one consisted of retrospective chart reviews--a list was pulled from the two 
offices for the pilot study.  All chronic pain management patients on opioid medication 
for greater than 90 days had their charts audited.  This list included all medications on the 
controlled substance II list prescribed by providers within these offices for the past six 
months.  Various medications were eliminated from the pilot including attention-deficit 
hyperactivity disorder medications.  This audit examined various documentation elements 
within the chart.  The first piece was to note if a pain management contract had been 
signed and scanned into the chart.  The next element assessed whether the ORT was 
completed.  Additionally, a thorough review assessed if the recommendations based on 
the ORT (Webster & Webster, 2005) risk stratification were followed.  For example, a 
patient found to be low risk based on the ORT would be required to have an office visit 
every six months only for prescription refills and an annual contract signed.  However, 
those found to be high risk would need to have office visits monthly or every other month 
along with the use of the prescription drug monitoring program (PDMP) to verify no 
other providers were prescribing controlled substances.    
Phase Two 
 Phase two encompassed provider and staff education on recent CDC (2016a) 
guidelines regarding pain management.  This occurred at a lunch and learn education 
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session.  Education covered included utilizing the pain management contract, ORT 
(Webster & Webster, 2005) assessment, the template created for pain management 
patients to improve documentation, where staff members should scan the items into the 
chart, and where staff could find documentation within the chart.  Additional education 
focused on PDMP access including delegate accounts and how to set up the delegate 
accounts.  The timeline for the education during the lunch and learn sessions was as 
follows: 
• Significance and background--five minutes 
• CDC guidelines regarding pain management--five minutes 
• Pain management contract-- five minutes 
• ORT assessment-- five minutes 
• Review the pain management template--10 minutes 
• Review where staff should scan pain management documents into the EHR -
-- five minutes 
• PDMP access and delegate accounts--10 minutes 
• Questions and answers--15 minutes 
 During the education session, each office was asked how this workflow could be 
introduced successfully for their particular office.  For example, the pain management 
contract and ORT assessment could be handed to the patient upon check in to the office, 
or they could be given to the patient by the clinical staff, or the provider could also give 
the patient these documents.  To have a successful implantation, their opinion was 
desired for the workflow process.   
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 Following the education, implementation of the pain management pilot began.  
Providers and staff within the offices were expected to follow CDC (2016a) guidelines 
and to utilize the screening tools following the risk stratification recommendations.  This 
phase occurred in January 2017 and lasted around three months.   
Phase Three 
 Phase three followed phase two and consisted of chart reviews of the same patient 
population identified in the previous chart audit to ascertain if improvement in 
documentation was achieved along with an increased frequency of office visits for the 
high-risk population.  This occurred in May of 2017.  The overall objective of this 
capstone and objectives was to detect if there was successful improvement in patient 
safety and pain management documentation.   
Method Analysis 
 Achieving statistical significance was highly desired within this capstone; 
therefore, ensuring this was met was thoroughly measured.  The practice has a patient 
base around 90,000 with 58 providers and eight locations in Northern Colorado.  This 
capstone was a pilot study completed at two offices in Northern Colorado.  The 
researcher hoped are to achieve a wide demographic of patients and also assess varying 
provider practices within two different locations.   
 To evaluate success or failure of a quality improvement project like this capstone, 
analyzing the outcomes was important.  Measuring patient care outcomes was assessed 
utilizing the Donabedian model (see Figure 4; Berwick & Fox, 2016).  The Donabedian 
model looks at structure, process, and outcomes (Berwick & Fox, 2016).  The structure 
within this capstone was very well set up.  The EHR utilized by the office is the same 
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EHR the local hospital system utilizes along with many of the coordinators within the 
community.  The EHR allows for templates to be created, which ensures certain 
documentation is completed prior to a notes completion.  This is known as a “hard-stop” 
in this particular EHR.  Within the template for pain management patients are various 
areas providers must select in order to finish their notes.  The personnel were trained on 
the aspects of this template along with where to scan pain management documents within 
the EHR.  Taking into account how the office preferred the documents to be delivered to 
the patient determined how personnel were trained regarding this intervention.   
 The process evaluated was how pain management was documented and 
completed following the education session with the new guidelines.  Various items 
assessed during the chart reviews in phase one and three were analyzed.   
 Finally, outcomes measured evaluated if pain management documentation and 
patient safety had improved.  This was measured by reviewing the same data points after 
the intervention had been completed.  A desired hope for the outcome was to improve 
pain management for the patient, the staff, and the providers.   
 
29 
 
 
Figure 5. The Donabedian model for patient outcomes (Berwick & Fox, 2016).  
 
 The statistical analysis was simply “yes or no” while conducting retrospective 
chart reviews.  Data points assessed pre- and post-intervention remained consistent to 
accurately measure if change occurred.  Simple statistics were utilized including how 
many patient charts were reviewed, the data points measured, and the diagnosis code.   
Summary 
 Addressing the opioid epidemic is of the utmost importance given the colossal 
problem contemporary practitioners are faced with regarding pain management.  
Improving pain management will not only benefit the providers but also the patient and 
support staff by assisting practitioners.  Documentation improvements would increase 
adherence to treatment plans by covering physicians and holding the patient accountable 
to goals discussed.    
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CHAPTER IV 
 
 
RESULTS  
 
 
Theoretical Framework 
 For this scholarly project, Rogers’ (1997) diffusion of innovation theory was the 
framework used to design and then disseminate information to the staff members within 
the practice.  The theory was selected to gain staff members’ acknowledgment regarding 
the necessity of change in a positive light.  Rogers’ theory was consistently utilized while 
creating the presentation for the education seminars.  Potential reasons for acceptance or 
refusal by the interdisciplinary team were anticipated.  Four concepts are essential to 
Rogers’ theory: innovation, communication, time, and social systems.  Innovation or the 
new idea introduced was improvement of documentation in the EMR for chronic pain 
management patients.  Communication surrounding the new idea began with the 
education seminars in addition to the innovation being addressed by the office managers 
at monthly meetings following the education session.  The concept of time as it relates to 
the theory addressed the phenomenon that individuals all arrive at either the adoption of 
the innovation or refusal of adoption at various times.  The main social system 
surrounding the innovation was the interdisciplinary team working at each of the 
implementation sites.  Each interdisciplinary team was concurrently tasked with a quality 
improvement assignment focused upon improved pain management documentation.  
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Findings and Outcomes 
 The main objective of the capstone project was to improve provider 
documentation of chronic pain management for patients in the primary care setting.  
Outcomes of the Doctor of Nursing Practice (DNP) project focused on documentation 
and increasing the frequency of pain management contracts signed by the patient.  
Increasing the use of a screening tool to assess for risky patient behaviors and to stratify 
patient risk for aberrant behavior would also be measured statistically.  Utilization of the 
PDMP and increasing the frequency of visits for high-risk patients was to be another 
measurable outcome.  Project objectives aligned with current CDC (2016a) guidelines to 
address the opioid epidemic plaguing the United States.  The CDC guidelines aimed to 
direct providers in the safe prescribing of pain medications and increase communication 
regarding pain management.  The clinic’s mission was to provide compassionate, 
exceptional, yet convenient care to everyone while in his or her neighborhood.  Project 
objectives matched the mission statement goals while addressing chronic pain 
management by the PCP, thereby promoting safe patient care locally.   
 Multiple barriers were encountered during the implementation phase of the 
capstone project, all of which are discussed in detail within this chapter.  As previously 
stated, there were three main objectives of the project.  Objective one was to conduct a 
retrospective chart review to evaluate baseline pain management documentation prior to 
implementation of the quality improvement project.  The second objective was to develop 
and implement an educational seminar for providers and other clinic staff that focused on 
improvement of documentation and introduction to and proper use of the ORT screening 
tool.  The educational seminar conveyed the importance and relevance of specific ways 
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clinician practice and care of chronic pain patients could be improved.  The goal of the 
third phase of the capstone project was to conduct retrospective chart reviews to assess 
for possible changes in documentation practices on pain management patients and an 
increase in the use of the ORT as well.    
 The pain management committee selected the ORT as the assessment of choice 
due to the ease of use, the amount of time it took to administer, and the specificity and 
sensitivity of the tool.  Background information on the development of the ORT tool 
stemmed from patients who were discovered to abuse pain medication and had been 
found to display risky behaviors (Webster & Webster, 2005).  Because of this, a tool was 
needed to assess risks of patient abuse or misuse of high-risk medication in the future to 
provide the clinician additional information to consider prior to prescribing high-risk 
medication (Webster & Webster, 2005).  Administering the ORT takes less than one 
minute and is designed to predict the risks of a patient abusing or misusing medication.  
“Because abuse and addiction are diagnosed by observing aberrant behaviors, knowing 
which patients are at greatest risk for displaying aberrant behaviors can be useful in 
establishing appropriate levels of monitoring for abuse” (Webster & Webster, 2005, p. 
433).  Initial studies by Webster and Webster (2005) focused on patients prescribed 
chronic pain medication; the ORT “exhibited a high degree of sensitivity and specificity 
for determining which individuals are at risk for opioid-related, aberrant behaviors” (p. 
432).   
 During the educational seminar, each provider in attendance was provided with a 
copy of the screening tool to use within daily practice to assess for patient risk of aberrant 
behavior.  All individuals present at the education seminar were shown the ORT and how 
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to score the assessment.  The researcher went through the 10 questions on the ORT and 
then provided the scoring sheet separately to discourage patients from any dishonesty 
when answering.  The scoring then placed the patient into a category of low, moderate, or 
high risk.  The pain committee had previously agreed on recommendations for each 
category of risk.  Low-risk patients would need an office visit every six months.  
Moderate-risk patients were to have office appointments every three months at a 
minimum for refills of their medications.  High-risk patients were recommended to have 
office appointments every month to every other month, random urine drug screens, and 
PDMP checks by the provider at his/her discretion.    
 While measuring the utilization of the tool after the educational session was not 
feasible due to barriers, the appropriate tool following the education seminar was given to 
the implementation sites.  The ORT tool was printed in color and then laminated; it was 
present in each exam room.  The clinical support staff was to hand the assessment to the 
patient who could then complete the assessment while waiting for the provider to enter 
the room.  The scoring sheet was provided to the clinicians and the clinical support staff 
to score after completion.  
 Objectives for the capstone project were to improve documentation of pain 
management patients, to utilize the PDMP when a patient was found to be in the high-risk 
category based off the ORT, and to increase the frequency of office visits of chronic pain 
management patients.  The CDC guideline (2016a) implementation at target clinics was 
another objective, which focused on clinician documentation.  Difficulty extracting 
information from the EMR led to this phase of the study being compromised.  This is 
discussed later in more detail.  Barriers contributing to the difficulty in meeting the 
  
34 
capstone objectives were not only faced by the researcher but also at the system-wide 
level.  In return, this affected project outcomes in their entirety.  
Results Linked to Problem Statement  
and Evaluation Plan 
 Project implementation was designed to occur within three critical phases.  Phase 
one consisted of retrospective chart reviews to establish a baseline for pain management 
documentation within the family practice at the two locations chosen for the pilot study.  
Criteria that eliminated patients from the pilot study included patients found to be on 
opioids for acute pain management, which for this capstone project was defined as opioid 
medication use for less than 90 days.  Additional demographics that eliminated patients 
from the study were age of the patient under 18 years, cancer diagnosis, hospice patient, 
and patients who were on controlled II substances that were not opioids.   
 Upon receiving IRB approval (see Appendix B) at the end of January, 
communication with leadership occurred to inform staff of all necessary specifics for the 
educational seminar.  Prior to the education sessions at the implementation sites, a 
thorough discussion with clinical leadership and pharmacy occurred to address potential 
barriers to successful project implementation.  During these discussions, the researcher 
also obtained accurate exam room counts to ensure each exam room received a colored, 
laminated copy of the ORT assessment.     
 The chief operating officer (COO) of the practice made a request to the EMR 
support specialist regarding the location of pain management contracts.  Within this 
particular EMR, tabs easily identified various portions of a patient’s chart.  Examples of 
these tabs included medications, imaging, consents, notes, and encounters.  A request was 
made for the pain management contracts to be scanned into the consent tab of the EMR 
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instead of the media tab, which is the current practice.  The media tab is utilized for all 
documents scanned into a chart, creating an overwhelming amount of items from which 
to search.  Examples of items within the media tab included specialty visit notes from 
providers who utilized another EMR, lab results performed at a laboratory outside of the 
hospital system, insurance cards, immunization records, medical-durable power of 
attorney, and pathology results.  Being difficult to remove the media section within the 
EMR, it was felt scanning the pain contract into the consent tab would be beneficial.  The 
EMR support specialist denied the request, stating the consent tab was to be used solely 
for consents approved by the larger healthcare system.  Examples for suitable use within 
the consent tab included consents for treatment and confidentiality consents.  Instead, it 
was deemed the pain contract would be scanned into the media tab under the name of 
“controlled substance contract.”  
 The first education seminar was conducted during the second week of February.  
Two of the three providers in the office attended.  The entire clinical support staff, which 
included three RNs, two licensed practical nurses (LPNs), two medical assistants (MAs), 
along with the five patient support staff (PSS) were in attendance.  The office manager 
and the clinical pharmacist were present as well.  The Doctor of Osteopathic Medicine 
(DO) who was unable to attend was emailed the PowerPoint presentation to review at 
their convenience.   
 The subsequent educational session was then completed at the larger of the two 
offices.  Four of the five practicing MDs at this site were in attendance.  The Chief 
Transformation Officer (CTO) who is also an MD, an NP from the practice, and two 
Doctors of Pharmacy (PharmD) were also in attendance.  Clinical support staff present 
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consisted of four RNs, three LPNs, two MAs, one emergency medical technician (EMT), 
and one nurse manager who is also an RN.  Also in attendance were eight PSSs, two of 
whom are front desk supervisors, the office manager, and the Chief Operating Officer 
(COO).  The two DOs in the office did not attend but they were emailed the PowerPoint 
presentation to review.  Unfortunately, the researcher was not informed if the providers 
reviewed the emailed PowerPoint at either implementation sites.   
 During the one-hour educational session, the pilot project was reviewed.  
Objectives for the presentation included the background, significance, and barriers of 
proper documentation and use of screening tools specific to primary care; CDC 
guidelines (2016a), and documentation expectations.  Additional areas of the education 
program focused on the importance of the ORT assessment and flagging of the patient’s 
chart within the EMR.  The presentation consisted of 29 slides the researcher reviewed 
with the staff.  It became clear during the educational sessions that clinician and staff 
frustration surrounding pain management practices was rampant based on the comments 
and stories told during the one-hour time frame.  Furthermore, attendees voiced 
appreciation for the capstone project objectives to improve clinician opioid practice and 
documentation.  Clinical and PSS staff members had many stories surrounding phone 
calls from frustrated patients and pharmacies and insurance companies denying 
medications and requiring a process called prior authorization.  Prior authorization occurs 
when the insurance provider does not approve a medication, test, or treatment until they 
get more information from the provider indicating the necessity of the requested 
medication, treatment, or test.  Not coincidentally, the information required as it related 
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to pain management and medications would all be nicely packaged within the pain 
template created by the facilities EMR specialist. 
 To increase staff engagement with the capstone project, deciding the particulars of 
the pilot’s workflow was given to each individual office.  For example, the larger of the 
two offices also had a great deal more staff available for quality improvement projects in 
general.  Previous quality improvement projects within this practice were felt to be 
successful due to each office’s individual tailoring.  The quality improvement (QI) 
coordinator encouraged input from all staff within the practice, creating a multi-
disciplinary team approach to many practice changes, often with staff presence and office 
flow.  What worked well for one office might not work well for another office with less 
staff or a busier environment.  The portion of the project up to the individual offices 
included deciding who would set the “for your information” (FYI) flag within the EMR, 
which would be activated upon completion of a pain management contract.  This FYI 
flag would say “pain management plan” and would also list the date when the patient 
signed the consent.  This flag would also serve as a reminder to obtain a new consent 
form the following year as every year a new consent is needed.  The researcher also 
educated the participants that all departments using this EMR would have the ability to 
see the FYI including the Emergency Department (ED).  The importance of utilizing this 
flag would provide continuity of care since other practices or facilities using the EMR 
would see this flag.  Within the pain management contract, the patient would agree to 
only obtain opioid medication from their primary care provider or, in their absence, a 
covering provider.  Therefore, if a patient requested chronic pain medication from 
another provider including an emergency room, it would be in violation of the contract.  
  
38 
The pain management contract discussed risks associated with opioid medications--
agreements the provider and patient must consent to such as the use of one pharmacy 
only.  Appendix A provides a copy of the pain management contract.  
 At each educational session, clinical staff and providers present were educated on 
the various items within the EMR that could improve from a documentation standpoint 
simply by using the template.  The pain template was reviewed with screenshots of the 
actual template, illustrating the depth and options within the note.  During the question 
portion of the education seminar at the larger office, providers showed significant 
concerns regarding changing their practice.  One provider asked if they would have 
negative marks as a result of not changing their practice per the goals of the pilot project.  
Another provider asked how to best document referrals to pain management coordinators 
due to their personal practice of not prescribing opioid medication for chronic pain 
management. 
 Following the completion of the education seminars, the clinical staff were 
provided with laminated, color copies of the ORT assessments (see Appendix C).  With 
this assessment readily available, clinic staff had the ability to give the assessment to 
each patient for them to complete with a dry-erase marker.  The assessment tool could 
then be charted and subsequently erased for the next patient encounter.  This method was 
selected to mirror existing self-assessment tools utilized by the practice such as a 
depression screening form, an anxiety questionnaire, and a personal and family history 
questionnaire related to cancer. 
 Documentation on pain management patients prior to this project had been 
completed in a variety of ways and was not consistent across the practices focused on in 
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the study.  In fact, documentation of pain management patients was not consistent even 
within each office and was also inconsistent across all offices.  In meetings held in the 
previous year with the pain committee, it was decided a pain management template that 
could encompass specific aspects within a patient’s chart or patient encounter specific to 
pain management and patient safety was necessary.  The committee assumed there would 
be a note that would address all of the necessary steps needed to accurately document in a 
clear manner within the practice’s EMR.  The QI specialist and PharmD at the practice 
asked the EMR’s support specialist to research what documents were available and how 
to utilize these tools within the EMR.  The EMR specialist, an employee for the larger 
healthcare system within the area, informed the QI specialist and PharmD that there was 
in fact a pain management template, but that this practice could not be granted access to 
utilize the document.  The reason for denial to access and utilize this document was not 
provided.      
 Therefore, the EMR specialist, a physician, within the practice was tasked with 
creating a template for the providers in the practice to use.  Along with the pain 
committee, the researcher brainstormed the necessary items needed within this template 
to safely and clearly document pain management.  Resources utilized to design the 
necessary items within the template included the CDC guidelines, physician input, and 
pharmacist input, along with the researchers input related to documentation 
improvements.  The EMR specialist then shared this template with every provider within 
the clinic and made the researcher and PharmD owners of the note.  To be listed as an 
owner of a note gives the authority to make changes and edit the note, resulting in 
changes that are reflected on every individual’s access.  The EMR specialist did make 
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some initial revisions to the note in order to ensure the note was user friendly.  The 
providers were encouraged to give feedback on the note, either good or bad in order to 
improve the template.   
Extent to Which Objectives Were Achieved 
 Vast barriers were encountered throughout the entirety of the project.  Therefore, 
objectives of the DNP project were not fully met.  The largest barrier perceived by the 
researcher was the inability of the EMR to pull an accurate list of pain management 
patients within the offices.   The design of the project hinged upon the first objective, 
surrounding an accurate chronic pain medication patient list, therefore, due to this 
problem, the remaining objectives were not met as proposed and outlined for the capstone 
project.  
 Although the researcher made multiple attempts to communicate with the QI 
coordinator at the practice requesting an accurate list of chronic pain patient charts for the 
review, regrettably, the list could not be obtained.  The QI coordinator informed the 
researcher that in the past, similar requests had been made from the practice to the EMR 
support team multiple times with no success; unfortunately, current access and lists 
generated were the only option.    
 Reasons provided for explaining the limitations in place for EMR changes were 
related to the number of practitioners utilizing the EMR platform.  The EMR at the 
implementation site was connected to an EMR also utilized by the larger health system 
within the area.  Because of this, the EMR lacked the ability to have customized areas for 
each clinic practice.  Once a request was made to change the EMR settings, a committee 
within the larger health systems central location then reviewed it.  Requests made by all 
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users of the EMR went through this process and occurred monthly.  Various sub-
categories of requests assisted the committee in its understanding of the request.  The 
process was in place to decrease unnecessary interruptions in operations; when changes 
are implemented, the system goes into downtime.  Downtime is when the EMR is 
unavailable so all charting is completed on paper and then re-entered into the system once 
it is back online.  The QI specialist relayed various frustrations surrounding the inabilities 
of the EMR to run even the simplest of reports due to roadblocks in place.   
Key Facilitators 
 Key facilitators of the capstone project included the clinical pharmacist, the office 
managers, and the nurse managers.  The office managers were instrumental in 
communicating the date and time of the lunch and learn sessions.  These two individuals 
sent email reminders out ensuring attendance.  The office managers were also helpful in 
reserving a room for the presentations at their offices.  In order for the researcher to 
present the PowerPoint, a projector was needed, which was organized and provided by 
the office managers.  Additional facilitators included office staff who were present during 
the lunch and learn sessions at the two locations.  The medical director of the practice 
was also a key facilitator for the capstone project as was the CTO of the practice.  The 
medical director was present at the pain committee meetings and stayed informed and 
supportive of the project along the way.  The CTO within the practice focuses on process 
improvement and quality improvement projects.   
 The CDC guidelines released in 2016 also facilitated the capstone project.  The 
CDC website also has various resources available to practitioners to provide additional 
information regarding opioid treatment.  The CDC created mobile applications 
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practitioners can download to their phone, allowing providers the ability to utilize the 
information on titration of opioids or access the guidelines themselves with ease (CDC, 
2017).  Other resources offered are documents that can be printed for providers and 
patients to have additional information on pain management including non-narcotic 
options for pain.  The CDC also created a checklist to guide providers on all necessary 
steps when considering opioid therapy for chronic pain (CDC, 2017).   
 Additional important key facilitators for this DNP project were capstone 
committee members.  Within the committee, the research advisor contributed greatly to 
the researcher for the entirety of the project.  The committee members were also 
instrumental in providing guidance and thoughts for the researcher.   
Key Barriers 
 Multiple barriers were encountered during the implementation and review of the 
capstone project: inability to access the shared drive, inaccurate lists hindering data 
collection, clinician concerns related to patient access and adequate time to spend on pain 
management, time constraints faced by the entire office, and the absence of workflow 
surrounding chronic pain management patients.  The largest and utmost problematic 
barrier was the inability to have an accurate list of pain management patients pulled from 
the EMR.   
 During phase one of the project, it was quickly discovered that the EMR utilized 
by the practice did not allow the QI specialist to request or pull specific reports.  The list 
available to the researcher included patients prescribed controlled II substances and their 
PCP as a provider within the pilot offices.  Upon reviewing the lists generated, multiple 
reasons were discovered that eliminated the patient from the pilot.  Of the patients 
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reviewed, it was found the opioid medication had not been prescribed within the past six 
months or the patient was on a controlled II substance that was not an opioid.  The list 
available was not user friendly as the researcher had to go from one document, an Excel 
spreadsheet, to the EMR to look up each individual patient.  When the EMR was 
accessed to review a patient’s chart, the first step was to review the medication list to 
determine if an opioid was prescribed within the past six months.  From there, the visit 
notes were reviewed to ascertain if the note delineated what follow up the provider 
requested.  The media section of the chart was reviewed to locate the existence of a pain 
management contract.  Additional areas reviewed included the patient’s problem list to 
determine if a diagnosis code was entered indicating the need for chronic pain 
management.   
 Once a chart revealed a controlled substance for pain management, the time 
necessary to review all the various intricacies within the chart was significant and 
restrictive.  More often than not, a patient had not been into the clinic within the last six 
months up to a year for an appointment or the medication was a one-time prescription 
and no refills had been requested or granted.  Finding patients to include in the pilot was 
not feasible with the list provided by the QI coordinator.  The list available to the 
researcher included patients who had not been seen by the clinic in many years, patients 
who had been prescribed acute pain management by a provider outside of the facility, and 
those who were prescribed controlled substances for items other than pain management.  
Per the QI coordinator, there was no way to filter the list to receive a more accurate list 
for the capstone project.  The researcher made attempts to use the list provided but 
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finding patient charts to include in the pilot was not possible with the additional barriers 
in place.   
 Additional barriers encountered resulted from the location of the list.  The patient 
lists created for the pilot project were stored on a shared drive only accessible to the 
researcher from a computer within the facility for privacy and security reasons.  Problems 
faced by the researcher included arriving to the implementation sites for research retrieval 
to find no computers were available.  After multiple attempts to conduct reviews resulted 
in the same outcome, the researcher reached out to the IT department to inquire if a spare 
or retired computer was available for use and was informed no extra computers were 
available.  The practice was undergoing significant growth, resulting in an increased need 
for computers for all new staff members.  This growth inhibited the researcher’s use of 
any additional computers at other locations.  
 From this point, the researcher decided to arrive on days when some providers 
were out of the office, hoping the clinic staff would also be off in order to utilize one of 
their computers.  Unfortunately, this was not a realistic option.  The researcher was 
informed that the majority of the time within this practice when there was an available 
desk, clinical “float” staff members were using the available space.  After hours data 
collection was not feasible due to implementation site policies and procedures.  The IT 
department felt an encrypted flash drive to store the patient list was a potential solution if 
this flash drive was stored in a locked drawer of the office manager’s desk.  The 
facilities’ compliance officer denied this request.  The medical director of the practice 
reached out to the compliance officer requesting an explanation on this denial.  If an 
explanation was provided, it was not shared with the researcher.   
  
45 
 The initial list received from the EMR included 1,665 patients from one office 
and 537 patients from the other office.  The list was obtained by using the following 
demographics: PCPs from the offices selected for the pilot, a controlled II substance 
prescribed, and the patient status if not deceased.  This list was not accurate for multiple 
reasons.  Many of the patients had the selected PCP listed as their provider; however, the 
controlled II substances they had been prescribed were from another provider outside of 
the facility.  For example, many patients had a hospitalization within the past several 
years and were prescribed a narcotic pain medication.  Many of the charts reflected 
orthopedic surgeries; patients were prescribed pain medication for acute reasons and had 
not been back to their PCP since the surgical procedure.  Due to the project not including 
acute diagnoses, these patients were excluded from the chart review.  Further chart 
reviews indicated these prescriptions were not within the last six months, were not 
prescribed by a provider within the clinic pilot, and had not been refilled.  The majority 
of the chart reviews showed prescriptions for acute pain treatment three years prior and 
the chart had not been updated to reflect a discontinued medication.  As stated previously, 
not all controlled II substances were included in the pilot such as ADHD medication.  
These patients were also on the list pulled from the EMR for the pilot, making the list 
largely inaccurate and increased the barriers to reviewing the information with such a 
large number of charts to review.   
 Within the pilot offices, providers had practiced from around three years up to 
over 35 years.  During the education session, providers expressed concerns regarding 
clinician practice change, which was a barrier to the pilot’s success.  These providers 
listened to the presentation and the question they verbalized regarding the capstone 
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project was related to receiving negative outcomes associated with their name if they did 
not change their documentation or prescribing practices.   
 Time constraints faced by the office were large.  The offices were busy practices 
with each provider seeing between 15-30 patients a day, leaving little time for office staff 
to conduct chart reviews to search for pain management contracts or ORT assessments.  
Often so much was going on during the operating hours of the clinic that the patients 
were in and out of the office rather quickly, leaving the clinical staff with many tasks to 
complete after patients departed.  Clinic staff expressed concerns regarding the potential 
implications of the project, increasing their already long list of tasks.  While this 
population of staff members was pleased with decreasing phone calls and frustrations 
surrounding pain management, they felt they had a great deal of work to do in not enough 
time.  Some of the more specific concerns focused on who would be responsible for 
determining if a patient needed a pain management contract or an ORT assessment and 
when patient follow up should occur.   
 Both providers and clinic staff expressed concerns with provider availability if 
increased office visits for chronic pain management patients were encouraged.  One 
provider voiced their schedule was booked out as far as three months in advance.  Other 
providers echoed this sentiment and feared they would not be able to accommodate more 
appointments.  The researcher assured the providers and clinical staff that increased 
appointments were recommended for high-risk patients; the appointments would allow 
for documentation of necessary items they were already addressing but not documenting 
properly.  Providers did admit they often had patients make appointments for other 
complaints and then expected their pain management to be addressed as well.   
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 Additional barriers of the project included a non-existent algorithm or workflow 
for pain management patients.  The nurse managers for the practice created workflows to 
provide a step-by-step guide to help walk clinicians through a process detailing each 
individual step of patient care within the software system.  The function of the workflow 
was to serve as a resource for individuals to easily utilize and navigate the task 
themselves.  Examples of previous workflows included how to document an influenza 
vaccine administered at the office or how to refill a prescription.  Prescription workflows 
detailed what lab work was necessary for various medications and how often the patient 
needed to present for an office visit.  The practice also had multiple quality improvement 
projects focused on population health workflows for their diabetic and hypertensive 
patients.  Pain management was felt to be a good next project but the workflows needed 
were not in place and were not available to be distributed.  The template created with the 
guidance of the pain management committee by the EMR specialist was done to improve 
documentation.  Providers appreciated the information within the pain management note 
but there was no way to insert the ORT tool within the note.  The EMR had many 
beneficial built in assessment tools that flowed seamlessly into a provider’s note.  For 
example, the depression-screening questionnaire was built within the EMR.  If 
completed, the provider could pull in this assessment to show quantitative data 
illustrating and supporting the medical decision-making.  These tools were used for 
screening purposes, upon diagnosis of depression, after treatment was initiated, and 
finally to reassess how the selected treatment was working.   However, the ORT 
assessment was not a tool the EMR utilized; therefore, there was no way to get the 
assessment to automatically populate into the pain management note or into any note 
  
48 
within the EMR.  The pain management note also had limitations as far as charting 
additional items not related to pain management.  Providers wanted to use the pain 
management note template but were unable to use this note unless the patient presented 
for pain management only.  For example, if the patient had a diabetes appointment, the 
provider used a much different template to document the necessary items for diabetes 
management.  If the provider also addressed the patient’s pain management at the same 
visit, the pain template could not be utilized simultaneously.  This feedback was provided 
to the office manager at all staff office meetings by the providers attempting to chart 
within the EMR system.  Unfortunately, due to the larger system refusing access to the 
existing note, the template created was not able to incorporate additional items.   
 Many providers saw patients not only for pain management but also for their 
annual exam, diabetes check, or for acute visits.  Current practices had limitations for 
patient access to providers including the need for more PCPs due to an aging population 
and improved treatments available for previously untreatable conditions.  An increase in 
patient panels for a provider decreased that provider’s availability for all appointments 
including pain management appointments.  Due to these limitations, pain medication 
refills had historically been granted without appointments.  Many patients had been 
conditioned to call monthly for their refills, thus eliminating office visits for pain 
medication continuation.  If pain management patients did present to the office, they 
often had other complaints addressed because of the limited availability of their provider.  
Additional reasons considered for patient resistance toward increased appointment 
intervals included insurance copays, patient time away from work, and patient ability to 
drive or have access to transportation.  
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Recommendations 
 Recommendations for this project to succeed would include pre-screening patient 
appointments to determine if a contract, screening tool, and pain note are warranted.  
Potential staff members with the access to conduct the pre-screening would include the 
provider seeing the patient or clinical staff reviewing the schedule.  For this proposal to 
work, each office would need to determine how this process could best be handled with 
their workflows.  One plausible workflow would involve clinical staff reviewing the 
schedule the day prior and flagging each patient who might present for chronic pain 
management.  The selected staff are felt to possess the most insight of patient patterns 
regarding pain management.  Clinical staff members often work on their providers’ tasks 
including medication refills, result notes, and patient questions.  Patients have the ability 
to call or send a message using the patient portal and often request refills and/or ask for 
advice.  When this occurs, the clinical staff is sent a message within the EMR.  Therefore, 
these staff would be aware of which patients called or had refills on a consistent basis.  
These staff would have the best ability to recognize the patients who might have frequent 
requests for controlled substances, early refills, and would be in need of an office visit.  
From there, those flagged patients could be communicated to the PSS staff who could 
then hand the patient a pain management contract and ORT assessment to be completed 
while waiting to be roomed.  Once roomed, the provider could take visual queues of 
seeing the contract and ORT to then document using an appropriate template and chart 
the ORT score.    
 Potential solutions regarding the lists available from the EMR system would be to 
utilize the available lists and meet with each provider at a time of their choosing to have 
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them review the patients and to highlight the patients they know are chronic pain 
management patients.  This is a benefit of primary care; the providers know their patient 
panels and can quickly identify to which patients they prescribe long term opioid 
medications.  This would eliminate the length of the list and provide the researcher with 
an accurate list to begin chart reviews.  Potential barriers with this plan include provider 
availability to review a lengthy list; however, by allowing the provider to select the time 
to meet might increase the likelihood of success.   
 Additional recommendations would be to delineate a specific and accurate list of 
pain management patients that would only include controlled II substances prescribed by 
the providers within the clinic and within the time frame proposed.  This was the original 
goal of the capstone project but barriers in place prevented an accurate list.  The system 
itself was not willing to allow changes to the list parameters.  Communication with the 
EMR support specialist and their supervising team requesting the ability to access an 
accurate list would be of utmost importance as primary care shifts to focus on population 
health.  Epic Systems (2016) is a large EMR platform used by many large health 
companies across the nation.  Researching how other practices have completed quality 
improvement projects and retrieved data would allow teams within large healthcare 
systems to review previously successful projects.  By having access to already instituted 
system changes, the steps to implement the necessary changes to retrieve data from the 
system would hopefully be received better.   
 Access to the shared drive where the lists were stored was another necessity for 
this project’s success.  Requesting access to the shared drive by utilizing an old or retired 
computer or by having a designated site where the research could be completed would 
  
51 
guarantee adequate data retrieval.  In hindsight, this step should have been completed at 
the project’s inception in order to provide access for the researcher.  This barrier was not 
a foreseeable hindrance to data collection by the researcher.   
 An additional recommendation would be to increase the presence of the 
researcher within the pilot offices to be available for questions and to remind staff of the 
pilot project.  By increasing the presence of the researcher, there would be a small chance 
that a computer could possibly become available, which might allow the researcher more 
access to the shared drive.  Possibilities of achieving this include attending every monthly 
staff and practice improvement meeting along with providing the front desk the resources 
needed to identify the patients needing a pain management contract signed.  Additional 
ideas would be to review the schedules ahead of time to identify chronic pain 
management patients and alert the clinical staff of the need for either a contract or ORT 
assessment to be completed.   
 As far as provider hesitation to change their practice when it comes to prescribing 
and documenting on pain management patients, providing additional education on the 
legal implications of poor documentation and unsafe prescribing could provide more 
incentive to increase the likelihood of change.  Plausible means to achieve this would be 
to have the malpractice insurance carrier return to the office and provide additional 
education to providers who attend.  Interestingly, this education was provided one year 
ago at the facility; however, much could change in a year and a reminder with specific 
case reviews would be useful.  This might also serve to increase provider buy in on the 
quality improvement project due to the fact that a provider inquired about negative 
outcomes if they did not change their practice.  It appeared providers considered change 
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if negatives were associated with their practice.  Encouragement from the chief executive 
officer, medical director, and CTO would be beneficial to increase provider attendance 
regarding this education. 
Unintended Consequences 
 Within the charts reviewed, it was discovered that medication lists were not 
current.  Within medicine, an accurate medication list is important, plays a role in 
determining medication interactions and safety, and could affect potential treatments or 
even avoidance of treatments.  While the researcher’s goal of the capstone project was to 
focus on improved documentation surrounding pain management, documentation of all 
items could be improved regardless of the patient population presenting for care.   
 Additionally, the providers expressed their lack of education on proper titration of 
chronic pain medication.  This presented an opportunity for the PharmD or a pain 
management coordinator to present and train PCPs to safely and confidently titrate pain 
medication.     
 The final unintended consequence as it related to this scholarly project not going 
as planned allowed the researcher the opportunity to think outside of the quintessential 
box and find potential solutions to the multiple barriers encountered.  This left the 
researcher feeling better prepared and more confident in designing and implementing 
practice change in the future as an APRN.   
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CHAPTER V  
 
 
RECOMMENDATIONS AND IMPLICATIONS 
 
 
 The main objective of this capstone project was to improve documentation of pain 
management patients on controlled II substances for longer than 90 days.  Two other 
objectives set forth were to use the PDMP when appropriate and to increase the 
frequency of office visits for those found to have moderate- and high-risk behavior as 
evidenced by the use of the ORT.  By aligning these objectives with the 2016 CDC 
guidelines regarding chronic pain and opioid prescriptions, evidence-based medicine was 
consistently at the forefront of this scholarly project.  
 Throughout the implementation of this project, many barriers were encountered.  
These barriers created challenges that affected the outcomes of the DNP project.  
Fortunately, these same barriers also helped bring to light the continued vigilance 
clinicians need to practice to improve documentation regarding pain management.  
Another compelling recommendation derived from the barriers encountered with this 
project was addressing clinician and staff concerns directly.  An easy way to complete 
this would be to formulate and approve a workflow algorithm for all appropriate 
implementation sites to utilize when an opioid medication refill request is received or 
when a patient presents for an appointment.  Encouraging a multi-disciplinary approach 
was key to facilitating this QI project.  Therefore, input from all staff should be 
welcomed during the creation of necessary workflow material.   
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 Some achieved outcomes of this scholarly project were the provision of the 
necessary tools and introduction of the 2016 CDC guidelines to the implementation sites.  
These tools included ORT assessments. access to the pain contracts. and access to the 
PDMP database.  Incorporating these items into the workflow has the potential to 
increase the adoption of the project goal of overall improvement of documentation on 
pain management patients.      
 A recommendation of continuing education for clinicians regarding the relevance 
and patient safety implications surrounding pain management is highly suggested.  
Clinicians are busy individuals; as such, they could benefit from continuing education on 
evidence-based practice updates along with patient safety recommendations.  Currently, 
this practice has a monthly best practice update given by various specialties within health 
care.  Ensuring that once or twice a year the topic of focus is on pain management would 
serve to remind providers of the need to improve documentation and strive to titrate 
patients to safe medication doses.  Pain management coordinators could present and 
perhaps this face-to-face meeting could improve provider relations and referral 
considerations to the specialty.  Bringing in pain coordinators to educate clinicians would 
increase provider knowledge and might also ease stigmas associated with pain 
management.  Fine et al. (2014) provided performance improving continuing medical 
education (CME) to clinicians caring for residents with long-term pain.  The data 
collected exhibited improvements in four of the five outcomes measured when compared 
to the baseline (Fine et al., 2014).  
 By utilizing the stated recommendations in Chapter IV, it is highly suggested this 
capstone project could be transformed and implemented to evaluate for any further 
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outcomes that might occur.  Future projects could utilize the same framework as this 
scholarly project but address the discussed barriers head on to evaluate if the project 
outcomes were altered in any way.  The necessity of pain management documentation 
will not fade with time.  Opioid medications are high-risk medications with potentially 
serious consequences including death.  Opioid abuse, prescription fraud, and unintended 
consequences of opioids continue to plague the country.  Improving communication 
between patients and providers, having clear and accurate documentation, along with 
utilizing screening tools to assess the risk for aberrant behavior coincides with the 
recommendations by the CDC (2016a).  Therefore, this project’s outcomes, even though 
minimal, aligned with evidence-based medicine.  Furthermore, successes of the project 
occurred even while encountering numerous barriers.  Successes like these provide 
evidentiary support of improved opioid prescription clinician practices--the focus of this 
project.   
 Implications for future practice would be to present the capstone project barriers 
faced by the researcher to the pain management committee at the practice.  
Recommendations for potential workarounds to continue the pilot would be provided.  
Unfortunately, due to successful completion of the intended degree, the researcher did not 
alter the project to included implementation of the recommendations.  Instead, staff 
members at the clinic have the opportunity to take on the quality improvement project 
while incorporating the recommendations.  
 Coincidentally, the implementation site has recently posted two positions that 
might be able to take on the capstone project.  One QI position for an RN or LPN would 
directly report to the QI coordinator, work on process improvement projects, and focus 
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on communication within the implementation sites.  A second position of a population 
management coordinator was the other position posted, which would be another option 
for an individual capable of continuing the project.  Documentation for people 
experiencing chronic pain needs improvement.  Because of this scholarly project, this 
pilot could continue with the incorporation of change theory to address clinician barriers.  
Recommendations within Chapter IV should also be addressed to ensure a more 
successful outcome regarding the vast barriers faced.   
 The overall goal for the capstone project was to improve documentation.  The 
pain management template is now available for providers to utilize.  This template is to 
be used when clinicians chart pain management patients.  While not every section within 
the template is required, the provider does have the option to use the portions they see fit 
based on their patient’s scenario.  Provider autonomy was consistently a focus when 
tailoring the clinical documentation template.  A focus was to maintain provider insight.  
Crucial aspects regarding pain management and patient safety were required within the 
note, thereby eliminating variation.  Furthermore, the template was created to neither 
punish thought processes nor punish clinicians.  The goal was to have clear 
documentation in order for another provider to review the note and know exactly what 
the provider would say if they happened to be out of the clinic.  Often, providers have a 
half-day off or even take a vacation.  Their patients still require medical care and when a 
patient calls or presents to the office for refills, this documentation would assist the 
covering clinician in deeming the appropriateness or inappropriateness of a request and 
would also serve to provide better care from a patient safety standpoint.   
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 As previously stated, primary care practices are prescribing nearly 50% of the 
pain management prescriptions (Hudspeth, 2016).  Allowing clinicians the opportunity to 
receive education surrounding safe pain management practices remains imperative.  
Surveys of physicians in the United States revealed clinicians felt they had “a lack of 
confidence in chronic pain management, concerns about the use of opioid analgesia, and 
dissatisfaction with training” (Johnson et al., 2013, p. 394).  Pain management 
coordinators will continue to have large wait times for new patients; therefore, the 
treatment will come from primary care clinicians.  Providing education specific to 
clinician practice for the treatment of pain will also better serve patients.  Also previously 
stated was clinicians providing the prescriptions for pain management have not had 
formal training surrounding pain treatment (Hudspeth, 2016).  Family practice physicians 
are required to receive 150 hours of CME every three years.  Of those CME hours, 75 
have to be education-specific to prescriptions.  If the American Academy of Family 
Physicians (2017) approved the CME on opioid education, these hours could count 
toward required CME.  American Nurses Credentialing Center (2017) requires ARPNs to 
complete 75 hours of continuing education for licensure renewal.  Therefore, this 
education would also count toward the requirements for APRNs.   
Project Limitations 
 Limitations within this capstone project were vast due to many unforeseen 
barriers encountered by the researcher.  Change within a well-established practice is 
difficult even with a multi-disciplinary team working toward the same goal.  Utilizing 
Kotter’s (cited in Moran, Burson, & Conrad, 2017) eight-step model regarding change 
allowed the researcher to view the project’s outcomes in a different manner.  Initial steps 
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utilizing Kotter’s model were to create urgency (Moran et al., 2017).  The researcher was 
involved in this when asked to join the pain committee at the implementation site.  
Discussions surrounded the need for improved documentation given the increase in pain 
management frustrations by providers along with large quantities of prescriptions 
provided during random chart audits by the medical director.  Following this step, the 
next step was to create a powerful coalition, which was exactly what the pain committee 
aimed to do.  This committee appreciated the researcher completing a DNP project on the 
subject of pain management and allowed the researcher to review relevant data to design 
a project.  This step was creating a vision for change--the third step in Kotter’s model 
(Moran et al., 2017).  After a vision was created, the next step involved communicating 
the vision, which occurred at the education seminars held at the implementation sites.  
Unfortunately, due to numerous barriers encountered, the outcomes of the project did not 
align with the focus objectives.  However, as stated, there were still implications for 
improved clinical practice change that occurred with this project.  The project could be 
adopted beginning from step five and carried to step eight of Kotter’s model--removal of 
obstacles--followed by creating short term wins, building on the changes, and finally 
anchoring change (Moran et al., 2017).   
Future of the Project 
 Krebs et al. (2014) discovered the barriers present hindered the “use of 
recommended opioid management practices: 1) inadequate time and resources for opioid 
management; 2) relying on general impressions of risk for opioid misuse; and 3) viewing 
opioid monitoring as ‘law enforcement’ activity” (p. 1150).  Inadequate time was a 
concern voiced by the pain committee prior to the capstone’s implantation.  The patient 
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access committee at the implementation site works to increase clinician availability.  A 
portion of the reason increased staff were at the implantation sites was to have improved 
provider access.  Resources were provided to the implementation sites including 
information on sites to review for more information--most importantly, the CDC’s 
(2016a) website for various handouts.  General impressions were discouraged; rather, this 
was the reason the ORT assessment tool was to be used for all pain management patients.  
This tool places the patient into a category, which then guides the provider on frequency 
of office visits, when to consider urine drug screens, and when to review the PDMP.  
 Evaluation of the project after the recommendations are in place was outside the 
time frame for this DNP scholarly project.  To continue this project, the Rogers’ (1997) 
theoretical framework should be altered and then applied to increase all staff receiving 
the change in a positive light.  Chronic pain management would continue to be a 
condition within primary care’s scope of practice.  Continuance of the project is essential 
to patient safety and should start by creating a multi-disciplinary workflow.  From there, 
the project could be disseminated to any clinician within the implementation site.   
 A future DNP student could adopt this project and focus on education sessions to 
clinicians on proper titration and management of pain medication.  Perhaps if a future 
DNP student implemented this project at a site that did not utilize the same EMR, they 
would have an increased chance of measuring change.  Furthermore, this would provide 
interesting insight into the realm of EMR documentation, in fact making high quality 
clinician practice more difficult.   
Another aspect that could be adopted by a future DNP student would be to 
address the clinician and staff concerns on how this change would affect their task 
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burden.  Providing examples of patient scenarios using the workflows to illustrate and 
guide staff might ease fears.  Many staff members expressed concern on how a project of 
this caliber would increase their workload and, therefore, would make another portion of 
their tasks suffer.  Utilizing staff resources and designing the project with this in mind 
would serve to ease the minds of staff on the front lines.   
 As a future APRN, the researcher plans to focus on proper documentation of pain 
management patients.  Future practice by the researcher will also utilize CDC (2016a) 
guidelines if a chronic pain management patient presents.  Advocating the use of pain 
management contracts, ORT assessments, and safe, thorough documentation will also be 
of high importance to the researcher.  Providing education and resources to coworkers 
regarding chronic pain management will also be a large part of the researcher’s future 
practice.   
Contribution to Personal Goals 
 The capstone project contributed to the researcher’s personal goals in multiple 
ways.  First and foremost, the transition into a nurse leader was epitomized by the 
capstone project.  While many differences exist when it comes to education to prepare for 
a Master of Science in Nursing (MSN) versus a DNP program, one of the main ones was 
the translation of research into practice.  According to Brown and Crabtree (2013), the 
DNP curriculum prepares nurses to not only possess leadership skills but also be 
competent in quality improvement approaches and have outstanding team-building 
abilities.   
 The researcher not only discovered a huge area with a need for a quality 
improvement project directly related to patient safety but also utilized the skills learned 
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within the DNP program to design the project.  The necessary preparation and 
communication completed prior to implementation of the project was paramount to the 
project’s development.  Despite not achieving all projected outcomes, the project was still 
a success in the eyes of the researcher and the PharmD.  Furthermore, because of the 
outcomes achieved with this project, the implementation site staff continues to discuss 
pain management and the need for improvement.   
 Additionally, the researcher has started to transition into the new role of APRN by 
completing this capstone project.  This was the largest personal goal achieved by the 
researcher.  This goal has been a work in progress since obtaining the Bachelor of 
Science in Nursing and realizing pursuing an advanced degree was the next goal.  
 Utilizing and living with the education and skills obtained from the DNP 
curriculum have allowed the researcher to become a better leader professionally.  
Knowledge of evidence-based practice, the critical thinking to recognize high-quality 
data, and the ability to realize the need for practice change are all skills this project has 
provided the researcher the chance to utilize.   
Evaluating Criteria of a Doctor of Nursing Project  
 Evaluating a DNP capstone project to meet the standards of the American 
Association of Colleges of Nursing (AACN) was done by utilizing five criteria.  
Waldrop, Caruso, Fuchs and Hypes (2014) established five criteria to evaluate if a DNP 
project was executed in accordance to American Association of Colleges of Nursing 
standards.  The meaning of the acronym EC as PIE stands for enhances, culmination, 
partnerships, implements, and evaluates (Waldrop et al., 2014).  These letters collectively 
form a pie, meaning they all are a piece of a larger puzzle.   
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 The letter E represents enhance--improving health or practice outcomes or 
improving health care policy (Waldrop et al., 2014).  The capstone project enhanced 
practice outcomes and aimed to improve health by utilizing CDC guidelines (2016a) 
regarding chronic pain management.  The project aimed to improve documentation on 
pain management patients found to be on chronic controlled II substances, increase the 
office visits for these patients, and identify risky behaviors by utilizing a screening tool-- 
the ORT.   
 The letter C in the equation stands for culmination; as defined by Waldrop et al. 
(2014), it is sufficient proficiency in the subject as well as practice inquiry.  This research 
project displayed culmination as the researcher became an expert regarding pain 
management in primary care and the necessary documentation and assessments that 
should be charted to improve patient safety and care.  The researcher utilized evidence- 
based practice while implementing the capstone project.  Additionally, the researcher 
conducted multiple requests to achieve the objectives of the project including requesting 
the ability to have the pain management contract scanned into the EMR, which would 
have allowed easier retrieval.    
 The letter P represents partnerships--defined as collaboration with 
interdisciplinary teams within the system that provides care (Waldrop et al., 2014).  The 
collaboration of the research project was highly important as the project was not 
achievable without collaboration.  The interdisciplinary team that was part of the 
education sessions included a PharmD, the CTO, the COO, MDs, NPs, RNs, LPNs, MAs, 
EMTs, PSSs, office managers, nursing managers, communication with the quality 
improvement coordinator, the medical director, and the research committee.  In addition, 
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the billing manager also reached out to the researcher regarding the billing aspects of the 
quality improvement project.   
 For the letter I, implementation was completed when research was translated into 
practice (Waldrop et al., 2014).  For this capstone project of pain management in primary 
care, it was quickly discovered during the meetings with the pain management committee 
that this was an area that needed improved documentation.  Random chart reviews 
revealed that of the patients who were on chronic pain management longer than six 
months but not in the past six months, therefore making them ineligible for the pilot, 
there was no documentation of a pain contract.  Additionally, there were no follow up 
directions or assessments related to the effectiveness of prescribed medication for pain 
control.  This illustrated the need for the capstone project.  During the lunch and learn 
sessions, education surrounding the importance of the project was provided as well as 
clear explanations regarding the CDC (2016a) guidelines.  Furthermore, the impact the 
pilot would have on staff and providers was delineated.   
 Evaluating the project, the final E in the equation, was done by evaluating the 
practice change and the outcomes (Waldrop et al., 2014).  While there was no statistical 
information from the project regarding specific evaluations after implementation, the 
pilot was a success.  The providers and staff within the pilot offices had pain management 
on their minds as they had been discussing it amongst themselves.  The office managers 
informally asked their offices how the pilot had been going; all felt this was a necessary 
change but admitted they had much upon which to improve.   
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Summary 
 Pain management in primary care will continue to be a part of daily medical care 
within practices.  Providers and staff will need to strive to improve documentation 
surrounding this patient population.  The controlled II substances and the risks associated 
with these medications are not something to be taken lightly.  Use of the CDC guidelines 
and recommendations were created to increase awareness of the dangers with these 
medications along with ways to safely prescribe and discontinue opioid therapy.   Every 
provider needs to have adequate documentation including a pain management contract 
signed annually, have a completed risk tool related to aberrant behavior and reassess 
these patients following a prescription.  Proper documentation surrounding these items is 
critical to patient safety in an age where opioid overdose occurs daily.  The CDC (2017) 
found that half of overdose deaths involve a prescription opioid.  The illicit drugs are no 
longer the sole cause for overdose resulting in death.   
 Arranging for the proper education surrounding pain management treatment will 
be imperative for clinician comfort when initiating, titrating or discontinuing an opioid 
medication.  Instituting collaboration within specialties and allowing for multi-
disciplinary teams to provide care to patients with chronic pain will also serve to improve 
patient safety.   
 The pilot project is recommended to continue, utilizing the recommendations set 
forth in chapter IV.  Upon discussion with the committee member within the practice, it 
was said that the staff and providers are now discussing pain management as a result of 
the education seminars.  The staff and providers are contemplating change, which is a 
step in the right direction.  The documentation of pain management patients continues to 
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be of great significance since the opioid epidemic has only continued to spread across the 
country.  The population management team or the soon-to-be appointed QI RN/LPN 
could take on the pilot in order to improve patient care and safety. 
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Informed Consent and Agreement for Chronic Opioid Therapy 
 
My primary care provider is prescribing chronic opioid medicine, sometimes called 
narcotic analgesics, to me for a diagnosis of:   
 
Alternative Treatment Options 
I am aware about the possible risks and benefits of other types of treatments that do not 
involve the use of opioids. The other treatments discussed include: 
 
  
Risks of Therapy 
• I am aware that the use of chronic opioid medicine has certain risks associated with it, 
including, but not limited to: sleepiness or drowsiness, constipation, nausea, itching, 
vomiting, dizziness, allergic reaction, slowing of breathing rate, slowing of reflexes 
or reaction time, physical dependence, tolerance to analgesia, addiction and 
possibility that the medicine will not provide complete pain relief. 
o I am aware that even if I do not notice it, my reflexes and reaction time might 
still be slowed. 
o I am aware that addiction is defined as the use of a medicine even if it causes 
harm, having cravings for a drug, feeling the need to use a drug and a 
decreased quality of life. I am aware that the chance of becoming addicted to 
my pain medicine is low. I am aware that the development of an addiction has 
been reported in medical journals and is much more common in a person who 
has a family or personal history of addiction.  
o I understand that physical dependence is a normal, expected result of using 
these medicines for a long time. I understand that physical dependence is not 
the same as addiction. I am aware physical dependence means that if my pain 
medicine use is markedly decreased, stopped or reversed by some of the 
agents mentioned below, I will experience a withdrawal syndrome. This 
means I may have any or all of the following: runny nose, yawning, large 
pupils, goose bumps, abdominal pain and cramping, diarrhea, irritability, 
aches throughout my body and a flu-like feeling. I am aware that opioid 
withdrawal is uncomfortable but not life threatening. 
o I am aware that tolerance to analgesia means that I may require more 
medicine to get the same amount of pain relief. I am aware that tolerance to 
analgesia does not seem to be a big problem for most patients with chronic 
pain; however, it has been seen and may occur to me. If it occurs, increasing 
doses may not always help and may cause unacceptable side effects.  
• I am aware that other medicines may interact with opioid medications. 
o Nalbuphine (Nubain™), pentazocine (Talwin™), buprenorphine 
(Buprenex™), and butorphanol (Stadol™), may reverse the action of the 
medicine I am using for pain control. Taking any of these other medicines 
while I am taking my pain medicines can cause a withdrawal syndrome. 
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o Alcohol, sleep aids, benzodiazepine medications (ex: Valium™, Xanax™), 
cough syrups, allergy medications, etc., may cause increased sedation when 
taken with my pain medicines and impair my ability to function.   
• Males Only: I am aware that chronic opioid use has been associated with low 
testosterone levels in males. This may affect my mood, stamina, sexual desire and 
physical and sexual performance. I understand that my provider may check my blood 
to see if my testosterone level is normal. 
• Females Only: If I plan to become pregnant or believe that I have become pregnant 
while taking this pain medicine, I will immediately call my obstetric doctor and this 
office to inform them. I am aware that, should I carry a baby to delivery while taking 
these medicines; the baby will be physically dependent upon opioids. I am aware that 
the use of opioids is not generally associated with a risk of birth defects. However, 
birth defects can occur whether or not the mother is on medicines and there is always 
the possibility that my child will have a birth defect while I am taking an opioid. 
 
 
Benefits/Treatment Goals 
• The use of opioids to treat chronic pain is controversial because of uncertainty 
regarding the extent to which they provide long-term benefit.  
• It should be understood that any medical treatment is initially a trial.  Continued 
prescription use is contingent on evidence of benefit.  Tolerance or failure to respond 
well to opioids may cause my provider to choose another form of treatment. 
• In general, the chronic use of opioid medicines may improve your ability to function 
and decrease your pain.  It is unlikely that your pain will be “zero” or completely go 
away.  It is unlikely that you will regain all previous functional ability prior to having 
this type of pain. 
 
Patient Expectations and Responsibilities 
• I agree to tell my provider my complete personal and family history to the best of my 
knowledge including all other medications, vitamins, supplements and treatments that 
I am receiving. I will notify my provider of any side effects I experience from any of 
my medications.   
• I will not be involved in any activity that may be dangerous to me or someone else if I 
feel drowsy or am not thinking clearly. Such activities include, but are not limited to: 
using heavy equipment or a motor vehicle, working in unprotected heights or being 
responsible for another individual who is unable to care for himself or herself. 
• I will only obtain medicines for my chronic pain from the provider whose signature 
appears below or, during his or her absence, by the covering provider, unless specific 
authorization is obtained for an exception. 
• I will obtain all of my medicines at the same pharmacy, when possible. Should the 
need arise to change pharmacies, our office must be informed. The pharmacy that you 
have selected is:_______________________________________________________    
• I will not take more of my pain medicine than what is prescribed by my provider.  
Taking more medication than prescribed could result in overdose.  Symptoms of 
overdose include sedation or loss of consciousness, difficulty breathing, and “pin-
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point” pupils.   
• I give the provider prescribing my chronic pain medicines permission to discuss all 
diagnostic and treatment details with pharmacists or other professionals who provide 
my health care 
• I will not share, sell, or otherwise permit others to have access to these medications.  
• I will take the highest possible degree of care when storing my medication and 
prescription as they may be hazardous or lethal to anyone who is not tolerant of their 
effects or may be sought by other individuals for misuse or abuse.  I will especially 
keep medications out of the reach of children and pets. 
• I will dispose of unneeded opioid medications by flushing them down the toilet.  I 
will not place them in the trash.  If I am unsure how to dispose of my medications, I 
will ask my provider or pharmacist. 
• I will tell all other healthcare professionals that I am taking an opioid as my pain 
medicine to prevent the risk of drug interactions or side effects. 
• I understand that I will need an office appointment every 90 days for refills.   
• I understand that I am to fill out a risk assessment tool and sign a pain contract 
annually.     
• I understand that failure to adhere to these policies may result in my provider no 
longer prescribing my opiate medication or referral for further specialty assessment. 
 
 
Provider Expectations and Responsibilities 
• Medications may not be replaced if they are lost, get wet, are destroyed, left on an 
airplane, etc. If your medication has been stolen and you complete a police report 
regarding the theft, an exception may be made. 
• Periodic drug testing (ex: urine, blood) may be requested, and your cooperation is 
required. Presence of unauthorized substances may prompt referral for assessment for 
addictive disorder. 
• The Colorado Prescription Drug Monitoring Program may be reviewed periodically 
to assess your adherence to prescribed treatment and this agreement.  
• Early refills will generally not be given. 
o Prescriptions may be issued early if the provider or patient will be out of town 
when a refill is due. These prescriptions will contain instructions to the 
pharmacist that they not be filled prior to the appropriate date. 
• Renewals/refills are contingent on keeping scheduled appointments.  Please do not 
phone for prescriptions after hours or on weekends.  Our office medication refill 
policy states that refills will be reviewed and sent within 72 hours.  Please plan to 
request your refills in accordance with this policy. 
• If the responsible legal authorities have questions concerning your treatment, as might 
occur, for example, if you were obtaining medications at several pharmacies, all 
confidentiality is waived and these authorities may be given full access to our records 
of controlled substance administration. 
• Annual risk assessment tool to be completed, contract signed, and updated on an 
annual basis. 
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I have read this form or have had it read to me. I understand all of it. I have had a chance 
to have all of my questions regarding this treatment answered to my satisfaction. By 
signing this form voluntarily, I give my consent for the treatment of my pain with opioid 
pain medicines. 
_______________________________________  ___________________________________ 
Patient Signature      Date   
 
________________________________________  ____________________________________
  
Patient’s Printed Name     Provider Signature  
 
Adapted from the American Academy of Pain Medicine consent form-Approved by the AAPM Executive Committee on January 14, 
1999 (2013). Updated 3/2014 
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OPIOID RISK TOOL 
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ORT Scoring (risk) 
0–3: low 
4–7: moderate 
≥8: high 
 
